disulfiram has been researched along with folic acid in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Casagrande, G; Michot, F | 1 |
Gibbs, DA; Watts, RW | 1 |
Dinarvand, R; Esfandyari-Manesh, M; Faghihi, S; Fasehee, H; Ghaffari, SH; Ghavamzadeh, A; Moradian, H | 1 |
Bu, W; Chen, M; Chen, X; Cui, J; Li, W; Li, X; Liu, C; Liu, J; Meng, L; Sun, H; Wang, J | 1 |
1 review(s) available for disulfiram and folic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for disulfiram and folic acid
Article | Year |
---|---|
Alcohol-induced bone marrow damage: status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals.
Topics: Alcoholism; Bone Marrow; Disulfiram; Erythroblasts; Erythrocytes, Abnormal; Ethanol; Ferritins; Folic Acid; Hematocrit; Hematopoiesis; Humans; Leukocyte Count; Liver; Platelet Count; Vitamin B 12 | 1989 |
7 other study(ies) available for disulfiram and folic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Biochemical studies on the treatment of primary hyperoxaluria.
Topics: Adolescent; Allopurinol; Child; Dietary Proteins; Disulfiram; Enzyme Inhibitors; Female; Folic Acid; Humans; Male; Metabolic Diseases; Oxalates; Pyridoxine; Vitamin K | 1967 |
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disulfiram; Drug Carriers; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Folic acid-modified disulfiram/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Disulfiram; Folic Acid; Humans; Mouth Neoplasms; Nanoparticles; Neoplastic Stem Cells; Organometallic Compounds; Retinal Dehydrogenase; Zinc | 2022 |